EVALUATED OF CLINICAL SYMPTOMS AND CHEST XRAY FINDINGS OF INH-RESISTANT TUBERCULOSIS
Main Article Content
Abstract
Purpose: Reseach the clinical and chest xray characteristics of characteristics of INH-resistant tuberculosis. Objective and method: A prospective, cross-sectional study of 168 INH – resistant TB patients were diagnostic and treatment at Pham Ngoc Thach Hospital, Ho Chi Minh City, from January 2019 to June 2019. We collected clinical data, laboratory tests and chest X-ray signs according base on medical records. Analysis of algorithm data base on statistical software and give results to research objectives. Results: Data from 122 men and 46 women, the average (and standart deviation, SD) of age for both sexes was 50,5, range 17-85 year – old, with an average of the younger age group of 22-55 years (47.7%). In out analysis, 73.8% patients had history of smoking and 25.6% patients had treated TB history. Long-term illness, 26.6% of cases 30 days of illness, 22.2% of 60 days. Common functional symptoms are cough, 89.9%; Fatigue, 85.7%; Sputum 73.2%; Weight loss 63.1%; Fever 61.3%. The physical symptoms were poor, the most common one was an explosion, accounting for 39.9%. Nearly two-thirds of patients have lesions in both lungs on the radiograph. Infiltrates are the most common lesions (97%). About 50% of pulmonary tuberculosis patients have a small area lesion on the radiograph. Conclusion: The medical history, time of illness, clinical symptoms and chest Xray findings had more different than new TB.
Article Details
Keywords
Tuberculosis, INH – resistant tuberculosis, isoniazid
References
2. Joo Hee Lee, M.D., Kyung-Wook Jo, M.D, Ph.D., and Tae Sun Shim, M.D, Ph.D (2018) Correlation between GenoType MTBDRplus Assay and Phenotypic Susceptibility Test for Prothionamide in Patients with Genotypic Isoniazid Resistance.www.e-trd.org, Tuberc Respir Dis, Published online.
3. Stagg HR., Lipman MC., McHugh TD (2017) Isoniazid resistant tuberculosis- a cause for concern? Int J Tuberc Lung Dis. 21 (2): 129–139.
4. Adithya Cattamanchi, Raymund B. Dantes (2009) Clinical Characteristics and Treatment Outcomes of Isoniazid Mono-Resistant Tuberculosis. Clin Infect Dis. Author manuscript; available in PMC 2010 Jan 15.
5. Leonela Villegas, Larissa Otero, Timothy R. Sterling (2016) Prevalence, Risk Factors, and Treatment Outcomes of Isoniazid- and Rifampicin- Mono-Resistant Pulmonary Tuberculosis in Lima, Peru. PLoS One, 2016; 11(4): 45-90.
6. Jhun BW, Koh WJ (2020) Treatment of Isoniazid-Resistant Pulmonary Tuberculosis. Tuberc Respir Dis (Seoul), 2020 Jan;83(1):20-30. doi: 10.4046
7. Nguyễn Thu Hà (2012) Nghiên cứu lâm sàng, cận lâm sàng, đột biến gen rpoB, katG và inhA của vi khuẩn trong lao phổi tái phát.Đại học Y Hà Nội, LATS Y học 62.72.24.01.